Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study

Trial Profile

Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2015

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial occlusive disorders
  • Focus Adverse reactions
  • Sponsors Covidien
  • Most Recent Events

    • 14 Aug 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 31 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.
    • 31 Jul 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top